Morgan Health

What Morgan Health does

Morgan Health is a wholly-owned business unit of JPMorgan Chase (NYSE: JPM), established to improve the quality, affordability, and equity of employer-sponsored health care in the United States. The unit functions as a strategic investor and research organization rather than a product company, deploying capital into mid-stage healthcare companies across five defined focus areas: primary care and navigation, data analytics, new coverage options, specialty and at-home care, and pharmacy. Its disclosed portfolio includes at least 13 companies such as Lantern (specialty care), Devoted Health (Medicare Advantage), Centivo (primary care-led health plans), Venteur (ICHRA), Aradigm Health (cell and gene therapy delivery), Cortica (pediatric neurodivergent care), Thyme Care (oncology specialty care), Merative (healthcare data analytics), Embold Health (provider analytics), and Personify Health, with check sizes ranging from $20 million to participation in a $317 million round.

Beyond capital deployment, Morgan Health publishes proprietary employer-focused research (including a 2026 SMB survey of 1,023 benefits decision makers and food-insecurity trend reports), maintains policy positions advocating reforms in value-based care and alternative plan design, and in 2026 launched the Small Business Health Care Hub, a digital resource platform targeting SMB benefits buyers. The unit is led by CEO Dan Mendelson and operates with 11-50 employees out of New York. Its business model is capital deployment on JPMorgan Chase's balance sheet, with value realization through portfolio company growth and exits; there is no disclosed pricing model, no standalone revenue, and no external paying customers.

Name

Morgan Health

Legal name

Morgan Health

Website

https://www.morganhealth.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Morgan Health is the healthcare investment arm of JPMorgan Chase, deploying capital into mid-stage companies across primary care, specialty care, pharmacy, data analytics, and new coverage to improve employer-sponsored health care for U.S. employers.

Ownership category

akta.pro rank

Product category

Healthcare Investment Services

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Business Services (B2B) Growth Equity (FSANACAD)

akta.pro secondary industry

Private/For-Profit Hospital Systems (HLAFAAAF)

Keywords

• Healthcare venture capital
• Employer-sponsored insurance
• Healthcare research insights
• Strategic health investments
• Small business benefits

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Strategic Investment Returns: Morgan Health generates value through equity investments in healthcare companies aligned to improving employer-sponsored health care. Returns are realized through portfolio company growth, exits, and market value appreciation rather than direct revenue from products or services.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Morgan Health is a strategic healthcare investor and research division of JPMorgan Chase that makes equity investments in mid-stage companies across five focus areas: primary care and navigation, data analytics, new coverage options, specialty and at-home care, and pharmacy. It complements its investment portfolio with employer-facing research and insights, policy advocacy for healthcare system reform, and the Small Business Health Care Hub, an educational resource equipping SMB leaders with tools to navigate health insurance decisions.

Product overview

Morgan Health is a business unit of JPMorgan Chase focused on improving employer-sponsored health care in the United States. Rather than operating a single product, Morgan Health functions as a strategic investor and research organization. Its core offering consists of investment commitments in mid-stage healthcare companies across five strategic focus areas (Primary care & navigation, Data analytics, New coverage options, Specialty & at-home care, and Pharmacy), complemented by an Employer Insights research program providing data-driven reports for benefits decision-makers, Policy Positions advocating for healthcare system reforms, and the Small Business Health Care Hub—an educational resource platform equipping small business leaders with tools and guidance to navigate health insurance decisions.

Differentiator

Problem solved

Functional benefit

Brands

• Small Business Health Care Hub: An educational resource developed by Morgan Health to help small and mid-sized businesses navigate health insurance decisions, providing tools, expert advice, and actionable insights.

Products and services

• Small Business Health Care Hub An online educational resource hub developed by Morgan Health that provides small and mid-sized business leaders with educational materials, tools, and actionable insights to navigate health insurance decisions with confidence.
• Investment Portfolio A portfolio of strategic equity investments in mid-stage healthcare companies aligned with Morgan Health's mission to improve employer-sponsored health care quality, affordability, and equity, spanning primary care, specialty care, pharmacy management, data analytics, and new coverage options.
• Employer Insights Data-driven insights and research reports, including surveys and trend analysis, designed to help employers make better health care decisions and meet the needs of their employees.
• Policy Positions Policy reforms and positions aimed at driving improvements in the U.S. health care system, with focus on value-based care, alternative health plan design, data, and workforce issues.

Quantifiable outcome

• Centivo helps save employers 15-30% on health insurance
• +3 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• General Catalyst: General Catalyst is a major venture firm with a substantial healthcare practice investing across stages. Comparable as a co-investor in mid-stage healthcare companies targeting employer and payer markets, with similar focus on care delivery transformation and health tech.
• GV (Google Ventures): GV is Alphabet's venture capital arm and a leading healthcare investor that participated in Devoted Health's Series F-Prime. As a broad tech-adjacent investor with a substantial healthcare practice, GV is a frequent co-investor and competitor in healthcare deals targeting employer-sponsored insurance innovations.
• Andreessen Horowitz (a16z Bio/Health): Andreessen Horowitz is a major venture firm with a dedicated bio/health fund that has co-invested with Morgan Health (e.g., Aradigm Health Series A). While broader in mandate, a16z Bio/Health is a frequent co-investor in healthcare deals targeting employer and consumer markets.

Direct peers

• Frist Cressey Ventures: Frist Cressey Ventures is a healthcare-focused venture firm that led Aradigm Health's $20M Series A alongside Morgan Health. Comparable as a dedicated mid-stage healthcare investor with a thesis around care delivery innovation and employer-relevant solutions.
• Oak HC/FT: Oak HC/FT is a venture firm focused on healthcare and financial technology, particularly fintech for healthcare and innovative care delivery. Comparable as a thematic mid-stage investor backing companies that improve employer-sponsored insurance economics and care quality.
• Kaiser Permanente Ventures: Kaiser Permanente Ventures is the corporate venture capital arm of Kaiser Permanente, investing in healthcare technology and services. Comparable to Morgan Health as an integrated payer-provider-backed investor targeting mid-stage healthcare companies serving employer and consumer markets.
• Echo Health Ventures: Echo Health Ventures is the strategic healthcare investment arm of Cambia Health Solutions, directly comparable to Morgan Health as a corporate-backed healthcare investor. Echo co-led Morgan Health's $30M Lantern investment, indicating overlapping thesis and co-investment partnership in mid-stage healthcare companies.
• Optum Ventures: Optum Ventures is the dedicated venture arm of UnitedHealth Group focused on healthcare innovation investments. As a strategic corporate VC with deep payer relationships, it pursues a comparable thesis to Morgan Health—backing companies that improve healthcare affordability, quality, and access.
• Town Hall Ventures: Town Hall Ventures is a healthcare-focused venture firm investing in companies serving vulnerable and underserved populations, including those on Medicare and Medicaid. Comparable to Morgan Health's focus on improving healthcare affordability and equity through strategic investments in innovative care models.
• CVS Health Ventures: CVS Health Ventures is the corporate venture arm of CVS Health, investing in healthcare innovation aligned with the parent's payer-provider-pharmacy strategy. Directly comparable to Morgan Health as a strategic corporate-backed healthcare investor targeting mid-stage companies across care delivery, pharmacy, and insurance innovation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/morganhealth
• LinkedInlinkedin.com/company/jpmorganchase

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments14 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Morgan Health